Adverse Effects of Intravesical OnabotulinumtoxinA Injection in Patients with Idiopathic Overactive Bladder or Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Studies.

Toxins (Basel) · 2024 · PMC11359369 · PMID 39195753

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Bladder Pain Despite the fact that an increasing trend of bladder pain was observed with onabotulinumtoxinA injection in patients with NDO, the incidence of bladder pain in the onabotulinumtoxinA group was not significantly higher than that in the placebo group (RR, 2.72; CI, 0.94–7.87; p = 0.07) ( Figure S6 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.